These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 18368052)

  • 1. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3.
    Kleinman ME; Yamada K; Takeda A; Chandrasekaran V; Nozaki M; Baffi JZ; Albuquerque RJ; Yamasaki S; Itaya M; Pan Y; Appukuttan B; Gibbs D; Yang Z; Karikó K; Ambati BK; Wilgus TA; DiPietro LA; Sakurai E; Zhang K; Smith JR; Taylor EW; Ambati J
    Nature; 2008 Apr; 452(7187):591-7. PubMed ID: 18368052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA interference: generic block on angiogenesis.
    Kalluri R; Kanasaki K
    Nature; 2008 Apr; 452(7187):543-5. PubMed ID: 18385725
    [No Abstract]   [Full Text] [Related]  

  • 3. [Unspecific effects of certain siRNA molecules used in the treatment of age related macular degeneration].
    Ebbesen M; Bek T; Pedersen FS; Jensen TG
    Ugeskr Laeger; 2010 Sep; 172(36):2457-9. PubMed ID: 20825735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient delivery of siRNA by atelocollagen in a murine laser-induced choroidal neovascularization model.
    Ito Y; Nozaki M; Sugitani K; Ashikari M; Hirano Y; Ogura Y
    Ophthalmologica; 2013; 230(4):215-21. PubMed ID: 24080835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small interfering RNAs induce target-independent inhibition of tumor growth and vasculature remodeling in a mouse model of hepatocellular carcinoma.
    Bergé M; Bonnin P; Sulpice E; Vilar J; Allanic D; Silvestre JS; Lévy BI; Tucker GC; Tobelem G; Merkulova-Rainon T
    Am J Pathol; 2010 Dec; 177(6):3192-201. PubMed ID: 20971743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
    Gu L; Chen H; Tuo J; Gao X; Chen L
    Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth.
    Cho WG; Albuquerque RJ; Kleinman ME; Tarallo V; Greco A; Nozaki M; Green MG; Baffi JZ; Ambati BK; De Falco M; Alexander JS; Brunetti A; De Falco S; Ambati J
    Proc Natl Acad Sci U S A; 2009 Apr; 106(17):7137-42. PubMed ID: 19359485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-interfering RNAs induce retinal degeneration via TLR3 and IRF3.
    Kleinman ME; Kaneko H; Cho WG; Dridi S; Fowler BJ; Blandford AD; Albuquerque RJ; Hirano Y; Terasaki H; Kondo M; Fujita T; Ambati BK; Tarallo V; Gelfand BD; Bogdanovich S; Baffi JZ; Ambati J
    Mol Ther; 2012 Jan; 20(1):101-8. PubMed ID: 21988875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of laser-induced choroidal neovascularization by nontargeted siRNA.
    Ashikari M; Tokoro M; Itaya M; Nozaki M; Ogura Y
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3820-4. PubMed ID: 20130283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical modifications on siRNAs avoid Toll-like-receptor-mediated activation of the hepatic immune system in vivo and in vitro.
    Broering R; Real CI; John MJ; Jahn-Hofmann K; Ickenstein LM; Kleinehr K; Paul A; Gibbert K; Dittmer U; Gerken G; Schlaak JF
    Int Immunol; 2014 Jan; 26(1):35-46. PubMed ID: 24065781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of gene therapy for treatment of age-related macular degeneration.
    Askou AL
    Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGFA Gene Silencing in CXCR4-Expressing Cells via siRNA Delivery by Means of Targeted Peptide Carrier.
    Egorova AA; Maretina MA; Kiselev AV
    Methods Mol Biol; 2019; 1974():57-68. PubMed ID: 31098995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morpholino-mediated increase in soluble Flt-1 expression results in decreased ocular and tumor neovascularization.
    Owen LA; Uehara H; Cahoon J; Huang W; Simonis J; Ambati BK
    PLoS One; 2012; 7(3):e33576. PubMed ID: 22438952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of small interfering RNA (siRNA) in targeting ocular neovascularization: A review.
    Supe S; Upadhya A; Singh K
    Exp Eye Res; 2021 Jan; 202():108329. PubMed ID: 33198953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of a novel siRNA-based anti-VEGF (siVEGF) nanoball for the treatment of choroidal neovascularization.
    Ryoo NK; Lee J; Lee H; Hong HK; Kim H; Lee JB; Woo SJ; Park KH; Kim H
    Nanoscale; 2017 Oct; 9(40):15461-15469. PubMed ID: 28976519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 3 signalling mediates angiogenic response upon shock wave treatment of ischaemic muscle.
    Holfeld J; Tepeköylü C; Reissig C; Lobenwein D; Scheller B; Kirchmair E; Kozaryn R; Albrecht-Schgoer K; Krapf C; Zins K; Urbschat A; Zacharowski K; Grimm M; Kirchmair R; Paulus P
    Cardiovasc Res; 2016 Feb; 109(2):331-43. PubMed ID: 26676850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
    Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
    Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin.
    Nakama T; Yoshida S; Ishikawa K; Kobayashi Y; Zhou Y; Nakao S; Sassa Y; Oshima Y; Takao K; Shimahara A; Yoshikawa K; Hamasaki T; Ohgi T; Hayashi H; Matsuda A; Kudo A; Nozaki M; Ogura Y; Kuroda M; Ishibashi T
    Gene Ther; 2015 Feb; 22(2):127-37. PubMed ID: 25503692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1.
    Shen J; Samul R; Silva RL; Akiyama H; Liu H; Saishin Y; Hackett SF; Zinnen S; Kossen K; Fosnaugh K; Vargeese C; Gomez A; Bouhana K; Aitchison R; Pavco P; Campochiaro PA
    Gene Ther; 2006 Feb; 13(3):225-34. PubMed ID: 16195704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 3 and geographic atrophy in age-related macular degeneration.
    Yang Z; Stratton C; Francis PJ; Kleinman ME; Tan PL; Gibbs D; Tong Z; Chen H; Constantine R; Yang X; Chen Y; Zeng J; Davey L; Ma X; Hau VS; Wang C; Harmon J; Buehler J; Pearson E; Patel S; Kaminoh Y; Watkins S; Luo L; Zabriskie NA; Bernstein PS; Cho W; Schwager A; Hinton DR; Klein ML; Hamon SC; Simmons E; Yu B; Campochiaro B; Sunness JS; Campochiaro P; Jorde L; Parmigiani G; Zack DJ; Katsanis N; Ambati J; Zhang K
    N Engl J Med; 2008 Oct; 359(14):1456-63. PubMed ID: 18753640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.